Publications - Page 41 sur 57 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Fibrose pulmonaire - FPI
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version.

Cottin V, Bonniaud P, Cadranel J, Crestani B, Jouneau S, Marchand-Adam S, Nunes H, Wémeau-Stervinou L, Bergot E, Blanchard E, Borie R, Bourdin A, Chenivesse C, Clément A, Gomez E, Gondouin A, Hirschi S, Lebargy F, Marquette CH, Montani D, Prévot G, Quetant S, Reynaud-Gaubert M, Salaun M, Sanchez O, Trumbic B, Berkani K, Brillet PY, Campana M, Chalabreysse L, Chatté G, Debieuvre D, Ferretti G, Fourrier JM, Just N, Kambouchner M, Legrand B, Le Guillou F, Lhuillier JP, Mehdaoui A, Naccache JM, Paganon C, Rémy-Jardin M, Si-Mohamed S, Terrioux P.

Respir Med Res. 2022 Aug 4;83:100948.
Fibrose pulmonaire - FPI
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective.

Cottin V, Tomassetti S, Valenzuela C, Walsh SLF, Antoniou KM, Bonella F, Brown KK, Collard HR, Corte TJ, Flaherty KR, Johannson KA, Kolb M, Kreuter M, Inoue Y, Jenkins RG, Lee JS, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nathan SD, Poletti V, Quadrelli S, Raghu G, Rajan SK, Ravaglia C, Remy-Jardin M, Renzoni E, Richeldi LK, Spagnolo P, Troy L, Wijsenbeek M, Wilson KC, Wuyts W, Wells AU, Ryerson CJ.

Am J Respir Crit Care Med. 2022 Aug 1;206(3):247-259.
Fibrose pulmonaire - FPI
Genetic testing in interstitial lung disease: An international survey.

Terwiel M, Borie R, Crestani B, Galvin L, Bonella F, Fabre A, Froidure A, Griese M, Grutters JC, Johannson K, Kannengiesser C, Kawano-Dourado L, Molina-Molina M, Prasse A, Renzoni EA, van der Smagt J, Poletti V, Antoniou K, van Moorsel CHM.

Respirology. 2022 Sep;27(9):747-757.
Fibrose pulmonaire - FPI
Clinical impact of TERT somatic mutation in telomerase-related gene mutation carriers after lung transplantation.

Ba I, Kannengiesser C, Mal H, Reynaud-Gaubert M, Cottin V, Hirschi S, Picard C, Borie R.

J Heart Lung Transplant. 2022 Sep;41(9):1207-1209.
Fibrose pulmonaire - FPI
Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.

Marinescu DC, Raghu G, Remy-Jardin M, Travis WD, Adegunsoye A, Beasley MB, Chung JH, Churg A, Cottin V, Egashira R, Fernández Pérez ER, Inoue Y, Johannson KA, Kazerooni EA, Khor YH, Lynch DA, Müller NL, Myers JL, Nicholson AG, Rajan S, Saito-Koyama R, Troy L, Walsh SLF, Wells AU, Wijsenbeek MS, Wright JL, Ryerson CJ.

Chest. 2022 Sep;162(3):614-629.
Fibrose pulmonaire - FPI
Ethnographic survey of patients and caregiver’s life journey in idiopathic pulmonary fibrosis.

Ahmed L, Bergot E, Prévot G, Cottin V.

Respir Med Res. 2022 Oct 1;83:100955.
Fibrose pulmonaire - FPI
Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis.

Cottin V, Spagnolo P, Bonniaud P, Dalon F, Nolin M, Kirchgässler KU, Van Ganse E, Belhassen M.

Respir Med Res. 2022 Nov 23;83:100951.
Fibrose pulmonaire - FPI
[Secondary pulmonary alveolar proteinosis in a transplant patient].

Chevereau-Choquet M, Marchand-Adam S, Mankikian J, Bergemer-Fouquet AM, Eymieux S, Flament T.

Rev Mal Respir. 2022 Nov;39(9):795-800.
Fibrose pulmonaire - FPI
GLPG1205 for idiopathic pulmonary fibrosis: a Phase 2 randomised placebo-controlled trial.

Strambu IR, Seemayer CA, Fagard LMA, Ford PA, Van der Aa TAK, de Haas-Amatsaleh AA, Modgill V, Santermans E, Sondag EN, Helmer EG, Maher TM, Costabel U, Cottin V.

Eur Respir J. 2022 Nov 3:2201794.
Fibrose pulmonaire - FPI
Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants Supports Functional Roles of MUC5B and DSP in Idiopathic Pulmonary Fibrosis.

Borie R, Cardwell J, Konigsberg IR, Moore CM, Zhang W, Sasse SK, Gally F, Dobrinskikh E, Walts A, Powers J, Brancato J, Rojas M, Wolters PJ, Brown KK, Blackwell TS, Nakanishi T, Richards JB, Gerber AN, Fingerlin TE, Sachs N, Pulit SL, Zappala Z, Schwartz DA, Yang IV.

Am J Respir Crit Care Med. 2022 Nov 15;206(10):1259-1270.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version.

Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective.

Genetic testing in interstitial lung disease: An international survey.

Clinical impact of TERT somatic mutation in telomerase-related gene mutation carriers after lung transplantation.

Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.

Ethnographic survey of patients and caregiver’s life journey in idiopathic pulmonary fibrosis.

Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis.

[Secondary pulmonary alveolar proteinosis in a transplant patient].

GLPG1205 for idiopathic pulmonary fibrosis: a Phase 2 randomised placebo-controlled trial.

Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants Supports Functional Roles of MUC5B and DSP in Idiopathic Pulmonary Fibrosis.